BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 75 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $97,984 | +21.9% | 15,855 | +0.2% | 0.00% | 0.0% |
| Q1 2024 | $80,371 | -16.4% | 15,821 | -1.4% | 0.00% | 0.0% |
| Q4 2023 | $96,086 | -88.9% | 16,041 | -86.9% | 0.00% | -85.7% |
| Q3 2023 | $866,040 | +8.3% | 122,322 | +7.7% | 0.01% | +16.7% |
| Q2 2023 | $799,435 | -25.4% | 113,556 | -11.7% | 0.01% | -33.3% |
| Q1 2023 | $1,072,232 | -32.5% | 128,565 | -7.1% | 0.01% | -35.7% |
| Q4 2022 | $1,587,959 | +20.0% | 138,324 | +31.7% | 0.01% | +16.7% |
| Q3 2022 | $1,323,000 | -3.6% | 104,999 | -19.1% | 0.01% | +9.1% |
| Q2 2022 | $1,373,000 | -24.7% | 129,723 | +15.8% | 0.01% | 0.0% |
| Q1 2022 | $1,823,000 | +5.3% | 112,030 | -10.4% | 0.01% | +22.2% |
| Q4 2021 | $1,732,000 | +788.2% | 125,095 | +822.3% | 0.01% | +800.0% |
| Q3 2021 | $195,000 | -93.9% | 13,564 | -94.9% | 0.00% | -87.5% |
| Q4 2014 | $3,222,000 | +44.0% | 264,963 | +15.8% | 0.01% | +60.0% |
| Q3 2014 | $2,237,000 | +559.9% | 228,740 | +760.2% | 0.01% | +400.0% |
| Q2 2014 | $339,000 | +34.0% | 26,591 | +11.2% | 0.00% | 0.0% |
| Q1 2014 | $253,000 | +88.8% | 23,919 | +35.8% | 0.00% | – |
| Q4 2013 | $134,000 | +10.7% | 17,610 | +6.3% | 0.00% | – |
| Q3 2013 | $121,000 | +290.3% | 16,565 | -17.3% | 0.00% | – |
| Q2 2013 | $31,000 | – | 20,032 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $50,998,000 | 20.86% |
| RTW INVESTMENTS, LP | 3,458,120 | $29,048,000 | 7.65% |
| ISZO CAPITAL MANAGEMENT LP | 307,366 | $2,582,000 | 4.49% |
| DAFNA Capital Management LLC | 541,128 | $4,545,000 | 3.84% |
| RA Capital Management | 3,489,795 | $29,314,000 | 3.60% |
| EMORY UNIVERSITY | 375,348 | $3,153,000 | 2.98% |
| Ghost Tree Capital, LLC | 1,500,000 | $12,600,000 | 2.35% |
| ACUTA CAPITAL PARTNERS, LLC | 920,310 | $7,731,000 | 1.83% |
| Avoro Capital Advisors LLC | 1,603,001 | $13,465,000 | 1.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,085,236 | $25,916,000 | 1.00% |